Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects

被引:32
作者
Bura, A.
Bachelot-Loza, C.
Ali, F. Dali
Aiach, M.
Gaussem, P.
机构
[1] Hop Europeen Georges Pompidou, INSERM U 765, Serv Hematol Biol A, F-75908 Paris 15, France
[2] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris 15, France
[3] Univ Paris 05, Paris, France
[4] INSERM, CIC 9201, Paris, France
关键词
D O I
10.1111/j.1538-7836.2006.02113.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2096 / 2097
页数:2
相关论文
共 9 条
  • [1] Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
    Aleil, B
    Ravanat, C
    Cazenave, JP
    Rochoux, G
    Heitz, A
    Gachet, C
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) : 85 - 92
  • [2] Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance
    Cattaneo, M
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) : 1980 - 1987
  • [3] P2Y12H2 haplotype is associated with peripheral arterial disease -: A case-control study
    Fontana, P
    Gaussem, P
    Aiach, M
    Fiessinger, JN
    Emmerich, J
    Reny, JL
    [J]. CIRCULATION, 2003, 108 (24) : 2971 - 2973
  • [4] Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
    Fontana, P
    Dupont, A
    Gandrille, S
    Bachelot-Loza, C
    Reny, JL
    Aiach, M
    Gaussem, P
    [J]. CIRCULATION, 2003, 108 (08) : 989 - 995
  • [5] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    Gent, M
    Beaumont, D
    Blanchard, J
    Bousser, MG
    Coffman, J
    Easton, JD
    Hampton, JR
    Harker, LA
    Janzon, L
    Kusmierek, JJE
    Panak, E
    Roberts, RS
    Shannon, JS
    Sicurella, J
    Tognoni, G
    Topol, EJ
    Verstraete, M
    Warlow, C
    [J]. LANCET, 1996, 348 (9038) : 1329 - 1339
  • [6] Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
    Matetzky, S
    Shenkman, B
    Guetta, V
    Schechter, M
    Bienart, R
    Goldenberg, I
    Novikov, I
    Pres, H
    Savion, N
    Varon, D
    Hod, H
    [J]. CIRCULATION, 2004, 109 (25) : 3171 - 3175
  • [7] Resistance to clopidogrel: A review of the evidence
    Nguyen, TA
    Diodati, JG
    Pharand, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) : 1157 - 1164
  • [8] Identification and biological activity of the active metabolite of clopidogrel
    Savi, P
    Pereillo, JM
    Uzabiaga, MF
    Combalbert, J
    Picard, C
    Maffrand, JP
    Pascal, M
    Herbert, JM
    [J]. THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) : 891 - 896
  • [9] Variability in platelet responsiveness to clopidogrel among 544 individuals
    Serebruany, VL
    Steinhubl, SR
    Berger, PB
    Malinin, AI
    Bhatt, DL
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) : 246 - 251